GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and ...

The authors commented that the patient’s "age, relative acute onset, and lack of medical history make this an atypical ...

BARCELONA, Spain I March 13, 2025 I SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations ...

"Although these drugs were developed to treat other disorders, including kidney disease, heart disease and high cholesterol, ongoing studies have shown they can reduce the risk of vision loss in ...

Learn more about whether Glaukos Corporation or iRhythm Technologies, Inc. is a better investment based on AAII's A+ Investor ...

The market was seeing Ocular Therapeutix (NASDAQ: OCUL) very positively this week, and that sunny view pushed the company's ...

This new steroid represents a significant advancement in the ophthalmic market, extending notable patient benefits, the company stated.

Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in vision-threatening diabetic retinal disease.

High levels of exposure to air pollution can increase the incidence of diabetic retinopathy and glaucoma, a recent study ...

Although the effect of diabetes on the retina is not completely understood ... "Although these drugs were developed to treat other disorders, including kidney disease, heart disease and high ...

Medically reviewed by Smita Patel, DO Migraine is a complex neurological disorder known for causing severe headaches. People ...